Age influences inflammatory responses, hemodynamics, and cardiac proteasome activation during acute lung injury

Experimental Lung Research

Volumn 41, Issue 4, 2015, Pages 216-227

  Linge, Helena M ^a   Lee, Ji Young ^a   Ochani, Kanta ^a   Koga, Kiyokazu ^a   Kohn, Nina ^a   Ojamaa, Kaie ^a,b   Powell, Saul R ^a,b   Miller, Edmund J ^a,b,c  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^c NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Aging; Inflammatory response; Myocardial proteasome; Pulmonary challenge

Indexed keywords

CYTOKINE; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; LIPOTEICHOIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDOGLYCAN; PROTEASOME; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; LIPOPOLYSACCHARIDE; TEICHOIC ACID;

ACUTE LUNG INJURY; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN SATURATION; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; HEART FUNCTION; HEART HEMODYNAMICS; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY INFILTRATE; LUNG ALVEOLUS; LUNG HEMODYNAMICS; LUNG LAVAGE; LUNG PERMEABILITY; MALE; MEMBRANE PERMEABILITY; MOUSE; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; THERMOREGULATION; AGING; ANIMAL; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CARDIAC MUSCLE; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISEASE MODEL; ENZYMOLOGY; HEMODYNAMICS; IMMUNOLOGY; LUNG; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PATHOPHYSIOLOGY; PNEUMONIA; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

ACUTE LUNG INJURY; AGE FACTORS; AGING; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; HEMODYNAMICS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE, INBRED C57BL; MYOCARDIUM; NEUTROPHIL INFILTRATION; PEPTIDOGLYCAN; PNEUMONIA; PROTEASOME ENDOPEPTIDASE COMPLEX; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TEICHOIC ACIDS; TIME FACTORS;

EID: 84928481598     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2014.999174     Document Type: Article

References (56)

1. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS: Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307:2526-2533.
2. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, Brochard L, Brower R, Esteban A, Gattinoni L, Rhodes A, Slutsky AS, Vincent JL, Rubenfeld GD, Thompson BT, Ranieri VM: The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38:1573-1582.
3. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685-1693.
4. Matuschak GM, Lechner AJ: Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment. Mo Med. 2010;107:252-258.
5. Liu G, Ye X, Miller EJ, Liu SF: NF-kappaB-to-AP-1 switch: a mechanism regulating transition from endothelial barrier injury to repair in endotoxemic mice. Sci Rep. 2014;4:5543. doi:10.1038/srep05543
6. Bull TM, Clark B, McFann K, Moss M: Pulmonary vascular dysfunction is associated with poor outcomes in patients with acute lung injury. Am J Respir Crit Care Med. 2010;182:1123-1128.
7. Zimmerman GA, Morris AH, Cengiz M: Cardiovascular alterations in the adult respiratory distress syndrome. Am J Med 1982;73:25-34.
8. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Jr., Hite RD, Harabin AL: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564-2575.
9. Erickson SE, Shlipak MG, Martin GS, Wheeler AP, Ancukiewicz M, Matthay MA, Eisner MD: Racial and ethnic disparities in mortality from acute lung injury. Crit Care Med. 2009;37:1-6.
10. Wheeler AP, Bernard GR, Thompson BT, Schoenfeld D, Wiedemann HP, deBoisblanc B, Connors AF, Jr., Hite RD, Harabin AL: Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006;354:2213-2224.
11. Kang CI, Song JH, Ko KS, Chung DR, Peck KR: Clinical features and outcome of Staphylococcus aureus infection in elderly versus younger adult patients. Int J Infect Dis. 2011;15:e58-e62.
12. Schreiber MP, Chan CM, Shorr AF: Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology. J Crit Care. 2011;26:395-401.
13. Meyer KC, Ershler W, Rosenthal NS, Lu XG, Peterson K: Immune dysregulation in the aging human lung. Am J Respir Crit Care Med. 1996;153:1072-1079.
14. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D.: Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344-353.
15. nd ed. Academic Press; 2007:637-673.
16. Powell SR: The ubiquitin-proteasome system in cardiac physiology and pathology. Am J Physiol Heart Circ Physiol. 2006;291:H1-H19.
17. Bulteau AL, Szweda LI, Friguet B: Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys. 2002;397:298-304.
18. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM: An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol. 2011;44:725-738.
19. Koga K, Kenessey A, Powell SR, Sison CP, Miller EJ, Ojamaa K: Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid Redox Signal. 2011;14:1191-1202.
20. Powell SR, Davies KJ, Divald A: Optimal determination of heart tissue 26S-proteasome activity requires maximal stimulating ATP concentrations. J Mol Cell Cardiol. 2007;42:265-269.
21. Kirk CJ, Powell SR, Miller EJ: Assessment of cytokine-modulated proteasome activity. In: Vancurova I, ed. Cytokine Bioassays. 1172 ed. New York: Springer; 2014:147-162.
22. Nelson S, Bagby GJ, Bainton BG, Wilson LA, Thompson JJ, Summer WR: Compartmentalization of intraalveolar and systemic lipopolysaccharide-induced tumor necrosis factor and the pulmonary inflammatory response. J Infect Dis. 1989;159:189-194.
23. Zhang P, Nelson S, Holmes MC, Summer WR, Bagby GJ: Compartmentalization of macrophage inflammatory protein-2, but not cytokine-induced neutrophil chemoattractant, in rats challenged with intratracheal endotoxin. Shock. 2002;17:104-108.
24. Dehoux MS, Boutten A, Ostinelli J, Seta N, Dombret MC, Crestani B, Deschenes M, Trouillet JL, Aubier M: Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med. 1994;150:710-716.
25. Millo JL, Schultz MJ, Williams C, Weverling GJ, Ringrose T, Mackinlay CI, van der Poll T, Garrard CS: Compartmentalisation of cytokines and cytokine inhibitors in ventilator-associated pneumonia. Intensive Care Med. 2004;30:68-74.
26. Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A: Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995;108:1303-1314.
27. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, Lopez CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG: Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA. 2013;110:3507-3512.
28. Takao K, Miyakawa T: Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci USA. 2014. pii: 201401965. [Epub ahead of print]
29. Starr ME, Saito H: Sepsis in old age: review of human and animal studies. Aging Dis. 2014;5:126-136.
30. Takahashi K, Koga K, Linge HM, Zhang Y, Lin X, Metz CN, Al-Abed Y, Ojamaa K, Miller EJ: Macrophage CD74 contributes to MIF-induced pulmonary inflammation. Respir Res. 2009;10:33:1-14.
31. Campbell EJ, Lefrak SS: How aging affects the structure and function of the respiratory system. Geriatrics. 1978;33:68-74.
32. Janssens JP, Pache JC, Nicod LP: Physiological changes in respiratory function associated with ageing. Eur Respir J. 1999;13:197-205.
33. Linge HM, Takahashi K, Lin X, Vasu VT, Metz C, Gohil K, Miller EJ: Role of macrophage migration inhibitory factor in a murine model of lung inflammation. Am J Respir Crit Care Med. 2009;179:A5651.
34. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E, Matthay MA: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis. 1992;146:427-432.
35. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 1993;341:643-647.
36. Gomez CR, Hirano S, Cutro BT, Birjandi S, Baila H, Nomellini V, Kovacs EJ: Advanced age exacerbates the pulmonary inflammatory response after lipopolysaccharide exposure. Crit Care Med. 2007;35:246-251.
37. Wenisch C, Patruta S, Daxbock F, Krause R, Horl W: Effect of age on human neutrophil function. J Leukoc Biol. 2000;67:40-45.
38. Hu M, Miller EJ, Lin X, Simms HH: Transmigration across a lung epithelial monolayer delays apoptosis of polymorphonuclear leukocytes. Surgery. 2004;135:87-98.
39. Hu M, Lin X, Du Q, Miller EJ, Wang P, Simms HH: Regulation of polymorphonuclear leukocyte apoptosis: role of lung endothelium-epithelium bilayer transmigration. Am J Physiol Lung Cell Mol Physiol. 2005;288:L266-L274.
40. Lee YL, Chen W, Chen LY, Chen CH, Lin YC, Liang SJ, Shih CM: Systemic and bronchoalveolar cytokines as predictors of in-hospitalmortality in severe community-acquired pneumonia. J Crit Care. 2010;25:176e7-176e13.
41. Rozenberg S, Tavernier B, Riou B, Swynghedauw B, Page CL, Boucher F, Leiris J, Besse S: Severe impairment of ventricular compliance accounts for advanced age-associated hemodynamic dysfunction in rats. Exp Gerontol. 2006;41:289-295.
42. Dunser MW, Hasibeder WR: Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med. 2009;24:293-316.
43. Kaye DM, Esler MD: Autonomic control of the aging heart. Neuromolecular Med. 2008;10:179-186.
44. Court O, Kumar A, Parrillo JE: Clinical review: myocardial depression in sepsis and septic shock. Crit Care. 2002;6:500-508.
45. Wang X, Robbins J: Heart failure and protein quality control. Circ Res. 2006;99:1315-1328.
46. Shen J, Reis J, Morrison DC, Papasian C, Raghavakaimal S, Kolbert C, Qureshi AA, Vogel SN, Qureshi N: Key inflammatory signaling pathways are regulated by the proteasome. Shock. 2006;25:472-484.
47. Keller JN, Hanni KB, Markesbery WR: Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech Ageing Dev. 2000;113:61-70.
48. Ferrington DA, Gregerson DS: Immunoproteasomes: structure, function, and antigen presentation. Prog Mol Biol Transl Sci. 2012;109:75-112.
49. Ren J, Wu S: A burning issue: do sepsis and systemic inflammatory response syndrome (SIRS) directly contribute to cardiac dysfunction? Front Biosci. 2006;11:15-22.
50. Huang H, Zhang X, Li S, Liu N, Lian W, McDowell E, Zhou P, Zhao C, Guo H, Zhang C, Yang C, Wen G, Dong X, Lu L, Ma N, Dong W, Dou QP, Wang X, Liu J: Physiological levels of ATP negatively regulate proteasome function. Cell Res. 2010;20:1372-1385.
51. Chatterjee PK, Yeboah MM, Dowling O, Xue X, Powell SR, Al- Abed Y, Metz CN: Nicotinic acetylcholine receptor agonists attenuate septic acute kidney injury in mice by suppressing inflammation and proteasome activity. PLoS One. 2012;7:e35361. doi: 10.1371A
52. Hyyti OM, Ledee D, Ning XH, Ge M, Portman MA: Aging impairsmyocardial fatty acid and ketone oxidation andmodifies cardiac functional and metabolic responses to insulin in mice. Am J Physiol Heart Circ Physiol. 2010;299:H868-H875.
53. Cullen SJ, Ponnappan S, Ponnappan U: Proteasome inhibition up-regulates inflammatory gene transcription induced by an atypical pathway of NF-kappaB activation. Biochem Pharmacol. 2010;79:706-714.
54. Tilahun AY, Theuer JE, Patel R, David CS, Rajagopalan G: Detrimental effect of the proteasome inhibitor, bortezomib in bacterial superantigen- and lipopolysaccharide-induced systemic inflammation. Mol Ther. 2010;18:1143-1154.
55. Wang X, Li J, Zheng H, Su H, Powell SR: Proteasome functional insufficiency in cardiac pathogenesis. Am J Physiol Heart Circ Physiol. 2011;301:H2207-H2219.
56. Sixt SU, Alami R, Hakenbeck J, Adamzik M, Kloss A, Costabel U, Jungblut PR, Dahlmann B, Peters J: Distinct proteasome subpopulations in the alveolar space of patients with the acute respiratory distress syndrome. Mediators Inflamm. 2012;2012:1-9.